Heparin- and basic fibroblast growth factor-incorporated degradable stent: comparison with traditional transmyocardial revascularization.

MLA

Zhang, G.Wei, et al. “Heparin- and Basic Fibroblast Growth Factor-Incorporated Degradable Stent: Comparison with Traditional Transmyocardial Revascularization.” The Journal of Cardiovascular Surgery, vol. 52, no. 2, Apr. 2011, pp. 261–70. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=21460777&authtype=sso&custid=ns315887.

APA

Zhang, G. W., Liu, X. C., Mphil, Y. L., Zhao, J., Shi, R. F., Zhao, X. B., Liu, T. J., Lü, F., Yang, Q., & He, G. W. (2011). Heparin- and basic fibroblast growth factor-incorporated degradable stent: comparison with traditional transmyocardial revascularization. The Journal of Cardiovascular Surgery, 52(2), 261–270.

Chicago

Zhang, G Wei, X C Liu, Y Luan Mphil, J Zhao, R Fang Shi, X Bin Zhao, T J Liu, F Lü, Q Yang, and G W He. 2011. “Heparin- and Basic Fibroblast Growth Factor-Incorporated Degradable Stent: Comparison with Traditional Transmyocardial Revascularization.” The Journal of Cardiovascular Surgery 52 (2): 261–70. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=21460777&authtype=sso&custid=ns315887.